Related by context. All words. (Click for frequent words.) 55 Prospective Randomized 55 Echocardiographic 55 Arch Neurol 54 Biological Effects 54 Molecular Diagnostic 54 Issues Relating 54 Consensus Statement 54 Arterial Hypertension 54 Process Validation 53 Practice Guideline 53 Clinical Significance 53 #:#-# [019] 53 Outcome Measures 53 Data Extraction 53 CHMP Opinion 53 Protein Structures 53 Gastric Cancer 53 Urgent Issues 53 Harmonization ICH 53 Adverse Event 53 Diabet Med 53 Clinical Outcome 52 Psychiatric Diagnosis 52 Proposed Revisions 52 ACCF AHA 52 Randomized Controlled Trials 52 Female Urology 52 EFNS 52 Malignant Lymphoma 52 Minimally Invasive Treatment 52 Treatment Outcome 52 NIH Consensus 52 Diagnostic Criteria 52 OARSI 52 Reproducibility 52 Risk Stratification 52 Ann Rheum Dis 52 XPEL Announces 52 Randomized Clinical Trials 52 Left Ventricular 52 Cardiotoxicity 52 Carotid Artery Stenting 51 Fast Skeletal Troponin 51 Clinical Efficacy 51 Hematological 51 Neurological Devices 51 Bioequivalence 51 Diagnostic Tests 51 Molecular Pathogenesis 51 Human Embryo 51 Vicor Technologies Announces 51 Multicenter Study 51 Schizophrenia Treatment 51 Gynecol Oncol 51 Intensive Care Medicine 51 Nicotine Vaccine 51 Thrombolytic Therapy 51 Immunomedics Announces 51 Test Methodology 51 Stent Placement 51 Clinical Practice Guidelines 51 Interoperability Standards 51 Whole Genome Sequencing 51 Multicenter Phase 51 Toxicogenomics 51 Statistical Methods 51 Antidepressant Treatment 50 Thromb Haemost 50 Suicidality 50 Protein Structure 50 Haemostasis ISTH 50 Hematological Cancers 50 SF #v# 50 Lung Injury 50 Guideline Update 50 Breast Ultrasound 50 Biobehavioral 50 Clinical Practice Guideline 50 Clinical Guideline 50 Radiation Induced 50 Practical Aspects 50 Content Outline 50 Acute Stroke 50 Refractory Angina 50 Pract 50 biostatistical analysis 50 Approvable 50 Implementers 50 Metabolic Disorder 50 Differential Diagnosis 50 Molecular Basis 50 Chronic Obstructive Lung 50 Renal Cancer 50 Clinical Decision Making 50 Novel Inhibitor 50 Acute Liver Failure 50 Analytical Methods 50 Pharmacogenomic 50 Natural Catastrophe Stress 50 Inflammatory Arthritis 50 Resubmission 50 Postdoctoral Position 50 Myocardial Perfusion 50 Multicenter 50 Headache Disorders 50 Cardiac Imaging 50 Adverse Outcomes 50 Eur Urol 50 Microstructural 50 Suppl. 50 Dosimetry 50 Arch Dermatol 50 J Pediatr 50 General Psychiatry #:#-#,# 50 Treatment Approaches 50 Expert Advisory Panel 50 Structural Changes 50 Clin Trials 49 Clinical Evaluation 49 C.2 49 Document Composition 49 Colorectal Screening 49 Prospective Multicenter 49 Newly Revised 49 FOR AN OPEN 49 Ethical Guidelines 49 Medicure Announces 49 Nat Genet 49 Antiviral Therapy 49 Shows Efficacy 49 J Clin Oncol 49 Laryngeal Cancer 49 Novel Therapeutic 49 Ann Oncol 49 Free Full Text 49 Mechanistic 49 Ghent PDF Workgroup 49 Epidemiological Studies 49 Hospital Acquired Pneumonia 49 Diabetic Foot Ulcer 49 Confirmatory 49 Clinical Validation 49 Stent Thrombosis 49 Apoptotic 49 Taxonomies 49 Marrow Transplant 49 National Guideline Clearinghouse 49 Practical Applications 49 Aggressive Reduction 49 Arch Intern Med 49 Horizon Scanning 49 Öko Institut 49 Devices Advisory Panel 49 COPERNICUS 49 Hormone Refractory Prostate Cancer 49 Predictive Toxicology 49 Neuromuscular Diseases 49 Main Outcome Measure 49 MBTOC 49 Adult Stem Cell Therapy 49 Meta analyzes 49 Mol Psychiatry 49 Tin Whisker 49 Results Confirm 49 Guidance Document 49 Near Infrared Spectroscopy 49 Dose Ranging 49 Left Ventricular Dysfunction 49 Patient Outcomes 49 Successful Implementation 49 Cardiometabolic Risk 49 Late Breaker 49 Logistic Regression 49 Neuroanatomy 49 Comparative Effectiveness 48 Storage Encryption 48 Liver Fibrosis 48 HYVET 48 Transdisciplinary 48 Autism Speaks Autism 48 Susceptibility Testing 48 Highlight Importance 48 Evaluation Process 48 Brain Stimulation 48 Improve Diagnosis 48 R3i 48 Blood Pressure Monitoring 48 TenFold Announces 48 Methodological 48 See CLINICAL PHARMACOLOGY 48 Continuous Disclosure 48 Angiogenic 48 Procedural Rules 48 Seasonal Influenza Vaccine 48 Pharmacologic 48 Proposed Rule Changes 48 Curr Opin 48 Tumor Response 48 Obes Res 48 ImmunoCAP ® 48 STEP BD 48 NCCN Drugs 48 Vapor Intrusion 48 number NCT# ClinicalTrials.gov 48 Severe Asthma 48 MEPAG 48 Continence Society 48 Unanimously Recommends 48 Cost Effectiveness 48 Imaging Techniques 48 Meta Analysis 48 Conformance Testing 48 Coronary Angiography 48 Mortality Risk 48 #:# -# Abstract Free [001] 48 FINA Doping 48 FASEB J. 48 J Am Coll 48 Placebo Controlled Trial 48 Anti Inflammatory Drug 48 Organic Synthesis 48 Human Pluripotent Stem 48 Quality Indicators 48 Adverse Effects 48 Multi Disciplinary 48 PEPP 48 Transocean thwarts 48 Lupus Drug 48 abstr 48 Makes Recommendations 48 Percutaneous Coronary Interventions 48 Opioid Use 48 Arpida Ltd. 48 Circulatory System Devices 48 Collaborative Approach 48 Ionizing Radiation 48 Appropriateness Criteria 48 #:#-# Abstract Free [003] 48 Breast Carcinoma 48 Psychosocial Factors 48 Pharmacoeconomic 48 Issues Surrounding 48 Industrial Hygienists 48 #:#-#,# [002] 47 Genetic Screening 47 J Rheumatol 47 Cervical Spine 47 Helps Predict 47 Biostatistical 47 Interoperability Test 47 Nucleic Acids Res 47 Cytotoxicity 47 Dry Powder Inhalers 47 FDA Advisory Panel 47 Prostate Disease 47 Investigational Drugs 47 Perinatal Care 47 OPTIMIZE 47 Machine Readable Travel 47 prospective multicentre 47 Neurol 47 Medication Adherence 47 GISSI 47 Inflation Targeting 47 Evolutionary Ecology 47 Depressive Symptoms 47 #:#-# Abstract Free [001] 47 Cost Estimating 47 Neurobehavioral 47 Concluding Remarks 47 I. INTRODUCTION 47 Multicenter Trial 47 Osteoarthritis Pain 47 PRISMA 47 Constitutive 47 Priestly Formation 47 Gynecologic Cancers 47 Preliminary Findings 47 Prognostic Factors 47 Hepatitis C Treatment 47 Diabetes Complications 47 COBIT Control 47 Electronic Archiving 47 Ann Emerg Med 47 Concluding Observations 47 Int J Epidemiol 47 Crystallographic 47 MiDAS 47 Ethical Considerations 47 Ischaemic 47 Randomized Double Blind Placebo 47 Prognostic 47 Skin Irritation 47 Regulatory Frameworks 47 Evolving Role 47 Psychiatry #:#-# [002] 47 Shows Promise Against 47 Ranolazine 47 SmartChip Human 47 Substantially Reduce 47 Cardiac Arrhythmia 47 Supramolecular Chemistry 47 FDA CDER 47 Anthropometric 47 Treating Chronic 47 Fact Conclusions 47 Plesk Control 47 Venous Thromboembolism 47 ACC AHA 47 Congenital Heart Surgery 47 Adjuvant Treatment 47 Toxicological 47 Brief Description 47 Implementation Guides 47 doi #.# 47 Nephrol Dial Transplant 47 Practical Guidance 47 Conformance Test 47 Multicentre 47 Endocrine Practice 47 Appendix B 47 Myocardial Perfusion Imaging 47 Dosage Forms 47 Respiratory Virus 47 VGA SVGA 47 Pivotal Phase II 47 Cites Flaws 47 Disclosure Requirements 47 #:#-# [018] 47 Total Knee Arthroplasty 47 Cervical Cytology 47 Alternative Methods ECVAM 47 Cancer Incidence Mortality 47 Resource Utilization 47 Multiscale Modeling 47 Breast Density 47 Cytometry 47 #:#-# [037] 47 Food Labelling 47 J Am Soc 47 Consumer Preferences 47 Metastatic Renal Cell Carcinoma 47 Pharmaceuticals Initiates 47 Gene Expression Analysis 47 Study Reinforces 47 Device Interoperability 46 Randomized Clinical Trial 46 Clinical Documentation 46 Patentability 46 ICH guidelines 46 Technical Specification 46 Nat Clin Pract 46 Thromboembolic 46 Neuroendocrine Tumors 46 Etiology 46 Prostate Cancer Outcomes 46 Meta Analyses 46 Vulnerability Description Language 46 Cholinesterase Inhibitors 46 Psychodynamic Psychotherapy 46 Solubility 46 Hemodialysis Patients 46 Bioeffects 46 Human Reproduction CERHR 46 Stable Angina 46 Regulatory Submissions 46 Myocardial Ischemia 46 Abstract Number 46 Emphasizes Need 46 Histologic 46 Oral Presentation 46 Antibacterial Drug 46 Functional Assessment 46 CT Scanning 46 POPRC 46 Help Detect 46 Counterparty Risk Management 46 Platelet Function 46 Improve Processes 46 Homeostasis 46 Microalbuminuria 46 Atmospheric Carbon Dioxide 46 Trandolapril 46 Asset Lifecycle Management 46 Standardization CEN 46 Recommends Approval 46 interrater 46 Ischemic Stroke 46 Quantitative Risk 46 Analytical Method 46 Metabolic Disease 46 Main Outcome Measures 46 Electronic Submission 46 Revised Recommendations 46 Psychiatric Illness 46 Panel SGIP 46 Corporate Governance Principles 46 Oral Fluid 46 Biological Sequence 46 Pharmacodynamic 46 Mass Torts 46 Relation Between 46 Testing Methodology 46 Human Neural Stem 46 Suppl 46 TFT LCD Panels 46 Oral Fingolimod 46 Erythropoiesis Stimulating Agents ESAs 46 Renal Transplantation 46 probation Victim Impact 46 Confirmatory Phase 46 Cancer Res 46 Future Directions 46 Public Use Microdata 46 Federal Service Impasses 46 Reproducible Research 46 Fully Compliant 46 Genentech Provides Update 46 retest reliability 46 Eligibility Requirements 46 J Affect Disord 46 Detection Evaluation 46 Endoluminal 46 Cardiovascular Radiology 46 Targeted Therapy 46 Intervention Trial 46 Polymorphism 46 Technical Specifications 46 Perinatal Mortality 46 Mass Spectroscopy 46 AFEP MEDEF 46 Molecular Genetic 46 Cardiovascular Risk Reduction 46 2nd edn 46 Doctrinal 46 Crit Care 46 Eugene Braunwald 46 Easily Manage 46 Screening Mammography 46 Racial Health Disparities 46 Clinical Implications 46 Prenatal Screening 46 Nerve Regeneration 46 Intravenous Formulation 46 ACC AHA ESC 46 Contents Introduction 46 Ambulatory Payment 46 Particle Size 46 Medicolegal 46 S# S# [001] 46 Growing Importance 46 Observational Studies 46 Plaque Psoriasis 46 Nephrol 46 GRI G3 46 Quadrivalent 46 Referential 46 Harmonisation 46 Stereotactic Radiosurgery 46 Compelling Case 46 Reperfusion 46 Psychometric 46 Pharmacokinetic PK 46 Cardiovascular Risk Factors 46 Sustained Efficacy 46 Stent Restenosis 46 Psychosom Med 46 Xenotransplantation 46 Accelerated Approval 46 SEBI Delisting 46 Vasc 46 Arch Facial Plast 46 Cervical Dysplasia 46 #/#/EEC [002] 46 Climate Modeling 46 IVSC 45 Multi Stakeholder 45 Nuclear Intentions 45 Dispute Mediation 45 Confirms Efficacy 45 Asylum Procedures 45 Carotid Endarterectomy 45 Renal Insufficiency 45 Immunogenicity 45 Randomized Phase III 45 Am J Clin 45 Prognostic Index 45 Satellite Transponders 45 Policies Procedures 45 Dialysis Outcomes 45 Bone Metabolism 45 Inhaled Nitric Oxide 45 J Child Adolesc 45 Drug Resistant Tuberculosis 45 CARE HF 45 Substance Dependence 45 Orally Active 45 Transparent Conductive 45 Avian Flu Vaccine 45 Viable Solution 45 Toxicity Testing 45 JNTU Kakinada 45 MEDCAC 45 J Urol 45 FOIA Requests 45 Peripheral Arterial 45 Biol Phys 45 Patellofemoral 45 ISHLT 45 Proxy Disclosure 45 Investigator Initiated 45 Predictive Value 45 www.irishtakeoverpanel.ie 45 Fundamentally Flawed 45 Antiplatelet Therapy 45 Nancy Leveson 45 Hyperlipidemia 45 Ad Impression 45 Fecal Incontinence 45 EFSA Panel 45 Photovoltaic Module 45 Cognitive Dysfunction 45 J Allergy Clin 45 Prehospital Emergency Care 45 Study Shows Benefits 45 #CFR# 45 Evaluation 45 enzyme immunoassay EIA 45 Decompensated Heart Failure 45 Randomized Study 45 Socioeconomic Status 45 Cardiac Marker 45 Hospitalized Patients 45 Personality Questionnaire 45 Pharmacokinetic 45 Educator Preparation 45 www.thetakeoverpanel.org.uk http:/www.thetakeoverGarrett Yrigoyen 45 Pathogen Detection 45 Duplicate Content 45 Conceptual Design 45 Practice Guidelines 45 SIMPADICO 45 Workplace Productivity 45 Digital Signatures 45 Radiation Therapy Oncology 45 Tumor Markers 45 SORT OUT III 45 Adjuvant Therapy 45 Proc Am Soc 45 Quantitation 45 Cytochrome P# 45 sample HMI Horticultural 45 Demonstrates Sustained 45 B.1 45 Breast Implant 45 Performance Benchmarks 45 Companion Animal Welfare 45 Randomized Double blind 45 Randomized controlled 45 Addiction Psychiatry 45 NASDAQ Listings Qualifications 45 Psychological Assessment 45 Cancer Biomarker 45 Technological Trends 45 Nonprofit Sector 45 ATOSS Software AG 45 Improve Quality 45 B2MML 45 Monographs 45 Expandable Polystyrene 45 Systematic Review 45 TEAP 45 Improving Efficiency 45 Selection Criteria 45 Cognitive Functioning 45 Nephrology Self 45 venous thromboembolic disease 45 Rheumatol 45 Complaint Handling 45 Blood Pressure Measurement 45 Solid Tumor 45 Universal Periodic 45 RE LY 45 BizAcumen LLC 45 NanoMarkets Releases 45 Invites Nominations 45 Computer Aided Detection 45 ADHERE 45 Sentinel Lymph Node 45 Observational Study 45 Improves Outcomes 45 Clinical Effectiveness 45 Parallels Plesk Control 45 Pharmacogenetic 45 Compliance Requirements 45 Hepatitis C Infection 45 Alternative Approaches 45 Pluripotent Stem Cells 45 TM Respiratory Viral 45 ACCLAIM COPD 45 Alzheimer Disease Genetics 45 Translational Molecular Medicine 45 Total Hip Arthroplasty 45 Heart Failure Therapy 45 Screening Tool 45 Self Efficacy 45 Prostate Cancer Survival 45 OSLER 45 Oral Presentation # 45 Molecular Mechanism 45 Neurodegenerative 45 Clin Oncol 45 Governance Structure 45 Currency Majors Technical 45 Regression Analysis 45 Prenatal Diagnosis 45 Histological 45 RE LY ® 45 Remote SQL Query 45 TB Vaccine 45 Corporate Governance Policies 45 Test Detects 45 Spoofing Vulnerability 45 GeSI 45 Bluetooth Qualification 45 ACCLAIM II 45 Oncological 45 Enhanced Workflow 45 EFSA GMO 45 Protein Folding 45 Safinamide 45 Liver Function 45 Recombinant DNA Advisory 44 morphometric vertebral fractures 44 Evaluation WISE 44 Categorization 44 Clinical Outcomes 44 Expert Discusses 44 Crack Sentences 44 Preventing Medication Errors 44 Incentive Compensation 44 Intersectoral 44 Oral Anticoagulants 44 Pressure Monitoring 44 Cardiol 44 #.#ap 44 Bone Metastases 44 KEMIRA 44 Mammographic 44 Intercomparison 44 Vertebral Fracture 44 Coronary Artery Calcium 44 Recommended Practices 44 Prostate Cancer Treatment 44 DSM IV Axis 44 Northeast Climate Impacts 44 #S #S [002] 44 Domain Name Dispute Resolution 44 NTIOL 44 Mineral Reserves Best Practices 44 Pandemic Influenza Vaccines 44 Cognitive Abilities 44 J Clin Psychiatry 44 Formative Assessment 44 Nutritional Status 44 Pulmonary Function 44 Urol 44 Substantial Reason 44 Safe Medication 44 Requirements Document 44 Castration Resistant Prostate Cancer 44 Text Revision 44 multicenter multinational 44 Clinical Trials Registry 44 DNA Microarray 44 Phenotypic 44 Secured Transactions 44 Antipsychotic Drug 44 Relationship Management System 44 Assessment Questionnaire 44 Postmarket 44 Patient Oriented 44 Clin Infect Dis 44 Eur J Cancer 44 Filibuster Fight 44 Medicare Reimbursement 44 Descriptor 44 Physica 44 Nonclinical 44 Ultrasound Imaging 44 Bioassays 44 icatibant 44 Add.1 44 J Clin Psychopharmacol 44 Adult Cardiac Surgery 44 Panel Faults 44 Acceptability 44 Calorimetry 44 Lung Cancer Trial 44 Spoken Language 44 Substantiation 44 Could Save Lives 44 Heat Dissipation 44 Retention Policies 44 Submission Guidelines 44 Play Crucial Role 44 Malaria Vaccine 44 Lung Cancer Detection 44 Preclinical Clinical 44 Practice Recommendations 44 Supportability 44 Randomised 44 Overviews 44 Yields Clues 44 Flexible Deployment 44 Risk Behavior 44 Cystatin C 44 Sleep Disturbance 44 Randomized Phase II 44 Stakeholder Workshop 44 Lung Cancer Screening 44 Pediatric Bipolar Disorder 44 Uniform Dispute Resolution 44 Rangeland Ecology 44 Uterine Cancer 44 Agency Prohibited List 44 Isotopic 44 #-#-# [072] 44 IPCC TAR 44 Corrective Actions 44 Osteoporos Int 44 RNAi Therapeutic 44 Cilostazol 44 journal Pharmacology Biochemistry 44 Vildagliptin 44 Matsushita Plasma Display 44 Proves Successful 44 Ensure Compliance 44 Complementarity 44 Intravenous Equipment 44 Psychiatr Serv 44 Interbody Fusion 44 Findings Reveal 44 Therapeutic Intervention 44 Unapproved Drugs 44 Stockholder Voting 44 Cellulite Reduction 44 OP# [001] 44 #:#-# Abstract Free [007] 44 Comparative Analysis 44 Provide Unprecedented 44 Further Validates 44 Authorized Generics 44 Splendid Medien AG 44 Breast Tissue 44 Racial Attitudes 44 IETF RFC 44 Protecting Intellectual Property 44 Recommends Changes 44 Physical Exams 44 Pharmacodynamics 44 Genetic Counseling 44 Novel Treatments 44 Fiber Optic Connectors 44 Liposuction Surgery 44 Ann Intern Med 44 Initiated Phase 44 AFNOR 44 #:# -# Abstract Free [002] 44 Prostate Screening 44 Integer Overflow Vulnerability 44 CT Angiography 44 Reduces Mortality 44 Reconstitute 44 Guidelines Issued 44 ACC AHA SCAI 44 SMARTREND NEWS 44 Reevaluation 44 aminotransferase 44 Diabetes Obesity 43 Unattended Payment 43 Study Validates 43 Audited Financials 43 Evaluation Criteria 43 Estrogen Receptor 43 Intercreditor 43 Silicone Breast Implant 43 Kidney Disease Outcomes 43 OpenGL Architecture 43 Eur Respir J 43 STRIDE PD 43 NIH Publication 43 NUREG 43 Prevalence Worldwide 43 Requirements Specification 43 Associative 43 Drugs Affecting Lipid 43 Fetal Heart 43 NAMUR 43 Psychological Effects 43 Valuation Standards 43 A/#/# [001] 43 Radiation Exposure 43 NanoMarkets Announces 43 Sweeping Reforms 43 Asthma Intervention 43 Secondary Hyperparathyroidism 43 Eminent Personalities 43 Antiviral Agents 43 Pandemic Flu Preparedness 43 Redesigned Deep Encased 43 Tasigna prolongs 43 NSABP B 43 Conformance 43 Functional Proteomics 43 NAIC Model 43 Datasheet 43 Study Shows Significant 43 C.4 43 ISSM 43 Captive Breeding 43 Primary endpoints 43 Antidepressant Medication 43 FDA Endocrinologic 43 Nonalcoholic Fatty Liver Disease 43 Silicone Breast Implants 43 Disciplinary Procedures 43 Critical Thinking Skills 43 System HCPCS 43 Electrotechnical Standardization CENELEC 43 Fingerprint Biometric 43 Multiple Myeloma Patients 43 Dispute Settlement Body 43 Neural Networks 43 Eukaryotic 43 Programming Languages 43 Spectral Imaging 43 Regular Quarterly 43 Self Administered 43 Dual Function 43 counseling Victim Impact 43 Hematopoietic 43 Common Procedure Coding 43 Pupil Accommodation Review 43 Treating Heart Failure 43 XRI 43 BEIR VII 43 Preclinical Evaluation 43 Histopathologic 43 Stem Cell Differentiation 43 Reissue CD 43 Protein Synthesis 43 Medical Malpractice Insurance 43 Clinical Modification 43 INDEPTH 43 Quartal 43 Metamodel 43 Essential Requirements 43 Indian Pharmacopoeia 43 Emerging Contaminants 43 Enables Faster 43 Ethical Issues 43 Seriously Flawed 43 Br J Cancer 43 Pastoral Formation 43 Urgent Intervention Triage 43 Enters Beta 43 Roadmapping 43 Immunohistochemistry 43 Modifiable 43 Competency Assessment 43 Semester Examination 43 ISO IEC Guide 43 www.sanbolic.com 43 Randomized Evaluation 43 clinicopathological 43 meta regression 43 Structured Authoring 43 Harsh Interrogation 43 Childhood Trauma 43 Distressed Investing Experts 43 Occupational Exposure 43 Non Conformance 43 Nanometer Design 43 Holds Successful 43 END FOOTNOTE 43 Buffer Overflow Vulnerabilities 43 Unequal Treatment 43 GHG Protocol 43 Shown Effective 43 Ozone Pollution 43 Better Outcomes 43 WORKING GROUP 43 #:#-# [002] 43 Usability Testing 43 PCI SIG Compliance 43 exploratory endpoints 43 Dissertations 43 Hr'g Tr 43 Zeitschrift für 43 Integer Overflow 43 member Ron Tjeerdema 43 ANSI X# 43 Antiviral Drug 43 Research Organizations CASRO 43 Judicial Nominees 43 Feasibility Analysis 43 Hormonal Therapy 43 EUROCAE 43 Febrile Neutropenia 43 Comorbidity 43 Acute Coronary 43 Committee OGIC 43 Product Roadmap 43 Publicly Available 43 Respiratory Viral Infections 43 Statistical Analysis 43 Steering Committee ISC 43 Sports Exerc 43 Issues Arising 43 Disease GOLD 43 Investigatory 43 Continuous Monitoring 43 SBSTTA 43 Vendor Selection 43 Hepatitis Virus 43 Security Bypass Vulnerability 43 EURIDIS 43 Being Evaluated 43 Tpull Weekly Marvel Comics 43 Regulatory Developments 43 Determination Letter 43 Acne Drug 43 Reaccreditation 43 Nullity 43 Radiation Effects 43 Arthritis Drugs 43 ASME Boiler 43 SoftLayer Launches 43 Heart Transplantation 43 Chronic Illness Therapy 43 TM Embolic Protection 43 Imposing Lawyer 43 Male Contraceptive 43 Helps Identify 43 Rheumatoid 43 Multivariate 43 Donor Coordination 43 AMA CPT 43 Childhood Asthma 43 Accelerated Assessment 42 Showed Significant 42 European Pharmacopoeia 42 Appellate Panel 42 Non Inferiority 42 Carotid Revascularization Endarterectomy vs. 42 Standardised 42 Quantifiable 42 Human Subjects 42 multicentre randomized 42 W3C XML 42 Common Terminology Criteria 42 Chemical Substances 42 Combinatorics 42 Bone Diseases 42 Sensorimotor 42 Injectable Fillers 42 Interagency Appraisal 42 AECB 42 Feature Extraction 42 Latest Advancements 42 MERLIN TIMI 42 #S #S [003] 42 Conforms 42 Pregnancy Outcomes 42 Variable Compensation 42 TELEPERFORMANCE 42 Metallurgy CIM 42 SVR# 42 AALAS 42 Partition Master 42 Practical Implications 42 Accountancy Profession 42 Concussion Assessment 42 Clin Endocrinol 42 Forrester Customer Experience 42 Favorable Decision 42 Annotation 42 Polysomnography 42 Cumulative Effects 42 GOP Presidential Hopefuls 42 SCD HeFT 42 Disciplinary Procedure 42 Food Additives 42 Genetic Diversity 42 Subpart E 42 Critical Component 42 controlled multicenter Phase 42 Patient Registry